Renalytix plc SEC filings RNLXY
Renalytix plc has 233 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 30, 2024 for the period ended Jun 30, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Jan 16, 2025 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Jan 16, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Dec 20, 2024 | Dec 19, 2024 |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Nov 19, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Nov 6, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, New debt, Listing notice, Unregistered share sale, Other events
|
Oct 1, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 27, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K/A |
Amended current report
Auditor change
|
Jun 25, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 24, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 28, 2024 | May 24, 2024 |
| 8-K |
Current report
Material agreement
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 26, 2024 | Apr 24, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Shareholder vote results
|
Apr 23, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 9, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 29, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 13, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 29, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Dec 18, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 18, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 3, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Results of operations
|
Sep 28, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 3, 2023 | Jul 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 3, 2023 | Jul 3, 2023 |
| 6-K | Current report (foreign issuer) | Jun 30, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jun 9, 2023 | Jun 9, 2023 |
| 6-K | Current report (foreign issuer) | Jun 9, 2023 | Jun 9, 2023 |
| 6-K | Current report (foreign issuer) | May 22, 2023 | May 22, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | Mar 30, 2023 | Mar 30, 2023 |
| 6-K | Current report (foreign issuer) | Mar 27, 2023 | Mar 27, 2023 |
| 6-K | Current report (foreign issuer) | Mar 21, 2023 | Mar 21, 2023 |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| 6-K | Current report (foreign issuer) | Feb 8, 2023 | Feb 8, 2023 |
| 6-K | Current report (foreign issuer) | Dec 20, 2022 | Dec 20, 2022 |
| 6-K | Current report (foreign issuer) | Nov 30, 2022 | Nov 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 29, 2022 | Nov 29, 2022 |
| 6-K | Current report (foreign issuer) | Nov 22, 2022 | Nov 22, 2022 |
| 6-K | Current report (foreign issuer) | Oct 25, 2022 | Oct 25, 2022 |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| 6-K | Current report (foreign issuer) | Aug 17, 2022 | Aug 17, 2022 |
| 6-K | Current report (foreign issuer) | Jun 30, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 27, 2022 | Jun 27, 2022 |
| 6-K/A | Filing | Apr 29, 2022 | Apr 29, 2022 |
| 6-K | Current report (foreign issuer) | Apr 1, 2022 | Apr 1, 2022 |
| 6-K | Current report (foreign issuer) | Mar 31, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | Dec 20, 2021 | Dec 20, 2021 |
| 6-K | Current report (foreign issuer) | Dec 7, 2021 | Dec 7, 2021 |
| 6-K | Current report (foreign issuer) | Nov 30, 2021 | Nov 30, 2021 |
| 6-K | Current report (foreign issuer) | Oct 21, 2021 | Oct 21, 2021 |
| 6-K | Current report (foreign issuer) | Aug 30, 2021 | Aug 30, 2021 |
| 6-K | Current report (foreign issuer) | Jul 28, 2021 | Jul 28, 2021 |
| 6-K | Current report (foreign issuer) | Jul 6, 2021 | Jul 6, 2021 |
| 6-K | Current report (foreign issuer) | Jun 25, 2021 | Jun 24, 2021 |
| 6-K | Current report (foreign issuer) | Jun 15, 2021 | Jun 15, 2021 |
| 6-K | Current report (foreign issuer) | Jun 10, 2021 | Jun 10, 2021 |
| 6-K | Current report (foreign issuer) | Mar 2, 2021 | Mar 2, 2021 |
| 6-K | Current report (foreign issuer) | Dec 7, 2020 | Dec 7, 2020 |
| 6-K | Current report (foreign issuer) | Nov 25, 2020 | Nov 25, 2020 |
| 6-K | Current report (foreign issuer) | Oct 27, 2020 | Oct 27, 2020 |
| 6-K | Current report (foreign issuer) | Sep 21, 2020 | Sep 21, 2020 |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RNLXY (OTC), RENXF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1811115
- Former names
- Renalytix AI plc (until Jun 25, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.